Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8955874 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 8 Pages |
Abstract
Patients with SCLC are at significant risk of developing CE posttreatment; RT is associated with an absolute increase in the rate of CE at 5 years of approximately 5% for all patients with SCLC and up to 10% for patients with LS-SCLC. Cardiac risk management and cardiac-sparing RT techniques should be further evaluated for patients with SCLC.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Matthew J. MD, Renjian MD, MPH, Madhusmita PhD, Suresh S. MD, Walter J. MD, Kristin A. MD,